Opko Health Inc
OPK.TA
| Exchange: | TA |
| Currency | Israeli Agora |
| ISIN: | US68375N1037 |
| LEI: | 529900A4S2D4OGOJLL02 |
| Primary Ticker: | OPK.US |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Diagnostics & Research |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates Bio Reference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (h GH-CTP), a once-weekly human growth hormone injection; and Factor VI Ia-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty AP Is; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida. |
| Address: | 4400 Biscayne Boulevard, Miami, FL, United States, 33137 |
| Website: | https://www.opko.com |
| Full Time Employees: | 3930 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 3907650816 |
| Market Capitalization Mln: | 3907.65 |
| EBITDA: | -165455008 |
| Book Value: | 2.00 |
| Earnings Share: | -1.24 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -0.33 |
| Operating Margin TTM: | -0.33 |
| Return On Assets TTM: | -0.08 |
| Return On Equity TTM: | -0.16 |
| Revenue TTM: | 716371968 |
| Revenue Per Share TTM: | 0.98 |
| Quarterly Revenue Growth YOY: | -0.31 |
| Gross Profit TTM: | 214300000 |
| Diluted Eps TTM: | -1.24 |
| Quarterly Earnings Growth YOY: | 0.19 |
Valuation
| Forward PE: | 66.22 |
| Price Sales TTM: | 5.45 |
| Price Book MRQ: | 0.74 |
| Enterprise Value: | 4781527525 |
| Enterprise Value Revenue: | 1.77 |
| Enterprise Value Ebitda: | -13.71 |
Shares
| Shares Outstanding: | 691987008 |
| Shares Float: | 283504288 |
| Percent Insiders: | 53.23 |
| Percent Institutions: | 27.22 |
Technicals
| Beta: | 1.63 |
| 52 Week High: | 635 |
| 52 Week Low: | 315 |
| 50 Day MA: | 576.57 |
| 200 Day MA: | 477.10 |
Earnings
| Report Date: | 2025-05-05 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | ILA |
| Report Date: | 2025-02-25 |
| Date: | 2024-12-31 |
| Before After Market: | After Market |
| Currency: | ILA |
| Report Date: | 2024-11-07 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | ILA |
| Report Date: | 2023-02-23 |
| Date: | 2022-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.11 |
| Eps Estimate: | -0.11 |
| Report Date: | 2022-11-08 |
| Date: | 2022-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.11 |
| Eps Estimate: | -0.08 |
| Eps Difference: | -0.03 |
| Surprise Percent: | -37. |
| Report Date: | 2022-08-04 |
| Date: | 2022-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.14 |
| Eps Estimate: | 0.01 |
| Eps Difference: | -0.15 |
| Surprise Percent: | -150 |
| Report Date: | 2022-05-09 |
| Date: | 2022-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.08 |
| Eps Estimate: | -0.06 |
| Eps Difference: | -0.02 |
| Surprise Percent: | -33.33 |
| Report Date: | 2022-02-24 |
| Date: | 2021-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.11 |
| Eps Estimate: | -0.02 |
| Eps Difference: | -0.09 |
| Surprise Percent: | -45 |
| Report Date: | 2021-07-29 |
| Date: | 2021-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.01 |
| Eps Estimate: | 0.02 |
| Eps Difference: | -0.03 |
| Surprise Percent: | -15 |
| Report Date: | 2021-04-28 |
| Date: | 2021-03-31 |
| Currency: | ILA |
| Eps Actual: | 0.05 |
| Eps Estimate: | 0.05 |
| Report Date: | 2021-02-18 |
| Date: | 2020-12-31 |
| Currency: | ILA |
| Eps Actual: | 0.05 |
| Eps Estimate: | 0.04 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 2 |
| Report Date: | 2020-10-29 |
| Date: | 2020-09-30 |
| Currency: | ILA |
| Eps Actual: | 0.04 |
| Eps Estimate: | 0.04 |
| Report Date: | 2020-07-30 |
| Date: | 2020-06-30 |
| Currency: | ILA |
| Eps Actual: | 0.05 |
| Eps Estimate: | -0.07 |
| Eps Difference: | 0.12 |
| Surprise Percent: | 171.42 |
| Report Date: | 2020-05-06 |
| Date: | 2020-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.09 |
| Eps Estimate: | -0.09 |
| Report Date: | 2020-02-26 |
| Date: | 2019-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.09 |
| Eps Difference: | 0.06 |
| Surprise Percent: | 66.66 |
| Report Date: | 2019-11-05 |
| Date: | 2019-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.11 |
| Eps Estimate: | -0.09 |
| Eps Difference: | -0.02 |
| Surprise Percent: | -22.22 |
| Report Date: | 2019-08-07 |
| Date: | 2019-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.1 |
| Eps Estimate: | -0.11 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 9.09 |
| Report Date: | 2019-05-07 |
| Date: | 2019-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.13 |
| Eps Estimate: | -0.09 |
| Eps Difference: | -0.04 |
| Surprise Percent: | -44.44 |
| Report Date: | 2019-02-27 |
| Date: | 2018-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.09 |
| Eps Estimate: | -0.09 |
| Report Date: | 2018-11-09 |
| Date: | 2018-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.05 |
| Eps Estimate: | -0.08 |
| Eps Difference: | 0.03 |
| Surprise Percent: | 37. |
| Report Date: | 2018-08-07 |
| Date: | 2018-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.01 |
| Eps Estimate: | -0.07 |
| Eps Difference: | 0.06 |
| Surprise Percent: | 85.71 |
| Report Date: | 2018-05-08 |
| Date: | 2018-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.08 |
| Eps Estimate: | -0.13 |
| Eps Difference: | 0.05 |
| Surprise Percent: | 38.46 |
| Report Date: | 2018-03-01 |
| Date: | 2017-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.32 |
| Eps Estimate: | -0.08 |
| Eps Difference: | -0.24 |
| Surprise Percent: | -30 |
| Report Date: | 2017-11-08 |
| Date: | 2017-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.08 |
| Eps Estimate: | -0.05 |
| Eps Difference: | -0.03 |
| Surprise Percent: | -6 |
| Report Date: | 2017-08-08 |
| Date: | 2017-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.04 |
| Eps Estimate: | -0.05 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 2 |
| Report Date: | 2017-05-09 |
| Date: | 2017-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.06 |
| Eps Estimate: | -0.04 |
| Eps Difference: | -0.02 |
| Surprise Percent: | -5 |
| Report Date: | 2017-03-01 |
| Date: | 2016-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.02 |
| Eps Estimate: | -0.04 |
| Eps Difference: | 0.02 |
| Surprise Percent: | 5 |
| Report Date: | 2016-11-07 |
| Date: | 2016-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.03 |
| Report Date: | 2016-08-08 |
| Date: | 2016-06-30 |
| Currency: | ILA |
| Eps Actual: | 0.02 |
| Report Date: | 2016-05-09 |
| Date: | 2016-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.03 |
| Report Date: | 2015-11-09 |
| Date: | 2015-09-30 |
| Currency: | ILA |
| Eps Actual: | 0.04 |
| Eps Estimate: | -0.02 |
| Eps Difference: | 0.06 |
| Surprise Percent: | 30 |
| Report Date: | 2015-08-05 |
| Date: | 2015-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.09 |
| Eps Estimate: | -0.05 |
| Eps Difference: | -0.04 |
| Surprise Percent: | -8 |
| Report Date: | 2015-05-11 |
| Date: | 2015-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.2 |
| Eps Estimate: | -0.08 |
| Eps Difference: | -0.12 |
| Surprise Percent: | -15 |
| Report Date: | 2015-02-27 |
| Date: | 2014-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.12 |
| Eps Estimate: | -0.06 |
| Eps Difference: | -0.06 |
| Surprise Percent: | -10 |
| Report Date: | 2014-11-07 |
| Date: | 2014-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.11 |
| Eps Estimate: | -0.07 |
| Eps Difference: | -0.04 |
| Surprise Percent: | -57.14 |
| Report Date: | 2014-08-11 |
| Date: | 2014-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.04 |
| Eps Estimate: | -0.09 |
| Eps Difference: | 0.05 |
| Surprise Percent: | 55.55 |
| Report Date: | 2014-05-09 |
| Date: | 2014-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.11 |
| Eps Estimate: | -0.1 |
| Eps Difference: | -0.01 |
| Surprise Percent: | -1 |
| Report Date: | 2014-03-03 |
| Date: | 2013-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.05 |
| Eps Difference: | 0.02 |
| Surprise Percent: | 4 |
| Report Date: | 2013-11-11 |
| Date: | 2013-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.17 |
| Eps Estimate: | -0.06 |
| Eps Difference: | -0.11 |
| Surprise Percent: | -183.33 |
| Report Date: | 2013-08-09 |
| Date: | 2013-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.04 |
| Eps Estimate: | -0.05 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 2 |
| Report Date: | 2013-05-09 |
| Date: | 2013-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.04 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 2 |
| Report Date: | 2013-03-18 |
| Date: | 2012-12-31 |
| Currency: | ILA |
| Eps Actual: | -0.01 |
| Eps Estimate: | -0.03 |
| Eps Difference: | 0.02 |
| Surprise Percent: | 66.66 |
| Report Date: | 2012-11-09 |
| Date: | 2012-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.03 |
| Report Date: | 2012-08-09 |
| Date: | 2012-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.04 |
| Eps Estimate: | -0.03 |
| Eps Difference: | -0.01 |
| Surprise Percent: | -33.33 |
| Report Date: | 2012-05-10 |
| Date: | 2012-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.02 |
| Eps Difference: | -0.01 |
| Surprise Percent: | -5 |
| Report Date: | 2012-03-15 |
| Date: | 2011-12-31 |
| Currency: | ILA |
| Eps Actual: | 0.06 |
| Eps Estimate: | -0.05 |
| Eps Difference: | 0.11 |
| Surprise Percent: | 22 |
| Report Date: | 2011-11-09 |
| Date: | 2011-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.03 |
| Eps Estimate: | -0.02 |
| Eps Difference: | -0.01 |
| Surprise Percent: | -5 |
| Report Date: | 2011-08-08 |
| Date: | 2011-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.02 |
| Eps Estimate: | -0.03 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 33.33 |
| Report Date: | 2002-04-02 |
| Date: | 2002-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.12 |
| Eps Estimate: | -0.15 |
| Eps Difference: | 0.03 |
| Surprise Percent: | 2 |
| Report Date: | 2001-10-24 |
| Date: | 2001-09-30 |
| Currency: | ILA |
| Eps Actual: | -0.18 |
| Eps Estimate: | -0.16 |
| Eps Difference: | -0.02 |
| Surprise Percent: | -12. |
| Report Date: | 2001-08-15 |
| Date: | 2001-06-30 |
| Currency: | ILA |
| Eps Actual: | -0.18 |
| Eps Estimate: | -0.02 |
| Eps Difference: | -0.16 |
| Surprise Percent: | -80 |
| Report Date: | 2001-04-01 |
| Date: | 2001-03-31 |
| Currency: | ILA |
| Eps Actual: | -0.1 |
| Eps Estimate: | -0.11 |
| Eps Difference: | 0.01 |
| Surprise Percent: | 9.09 |
| Date: | 2024-09-30 |
| Date: | 2022-12-31 |
| Eps Actual: | -0.4 |
| Date: | 2021-12-31 |
| Eps Actual: | -0.0 |
| Date: | 2020-12-31 |
| Date: | 2019-12-31 |
| Eps Actual: | -0.3 |
| Date: | 2018-12-31 |
| Eps Actual: | -0.2 |
| Date: | 2017-12-31 |
| Eps Actual: | -0. |
| Date: | 2016-12-31 |
| Eps Actual: | -0.3 |
| Date: | 2014-12-31 |
| Eps Actual: | -0.3 |
| Date: | 2013-12-31 |
| Eps Actual: | -0.2 |
| Date: | 2012-12-31 |
| Eps Actual: | -0.1 |
| Date: | 2011-12-31 |
| Eps Actual: | -0.5 |